The major pharmaceutical company Allergan, owned by AbbVie, has issued a recall of two eye ointments under the ... The FDA ...

AbbVie receives US FDA approval for Emblaveo to treat adults with complicated intra-abdominal infections with limited or no treatment options: North Chicago, Illinois Monday, Febr ...

CEO Richard Francis reflects on Teva’s return to growth during his tenure, and what’s next for the drugmaker in its quest to ...

Biosimilars have been on the market in Europe since 2007 but have had a larger impact on Amgen since 2019 as US exposure intensifies. Pressure on Prolia/Xgeva is coming in 2025. Amgen's pipeline had ...

It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.

AbbVie’s Skyrizi was responsible for the highest TV advertising outlay in pharma in most months of 2024, but 2025 is starting off on a very different note. According to iSpot.TV’s analysis of ...

MongoDB is a trade and not an investment, Cramer says. Jim Cramer recommends buying AbbVie , saying it’s "just a gem." Next: Access Our New, Shockingly Simple 'Alert System' On Jan. 31 ...

In this article, we are going to take a look at where AbbVie Inc. (NYSE ... I know that the president said on Friday that he doesn't care what the stock market says about his tariffs, but that's ...

Abbott Diabetes Care ... of AbbVie In 2011, Abbott announced it was to separate into two leading healthcare companies by the end of 2012. One was to be a diversified medical products company ...

These are the best vitamins and supplements for eye health, which are great for supporting your vision and helping you take ...